Dong-Sheng Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Dong-Sheng Zhou has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Fan-Bin Meng
Department of Orthopedics, Linyi People's Hospital Affiliated to Shandong University, Linyi, 276000, Shandong, People's Republic of China
1 shared publicationWei Wang
Department of Orthopedics, Linyi People's Hospital Affiliated to Shandong University, Linyi, 276000, Shandong, People's Republic of China
1 shared publicationXiang-Zhen Han
Department of Orthopedics, Linyi People's Hospital Affiliated to Shandong University, Linyi, 276000, Shandong, People's Republic of China
1 shared publicationXiao Li
Department of Orthopedics, Linyi People's Hospital Affiliated to Shandong University, Linyi, 276000, Shandong, People's Republic of China
1 shared publicationYong-Qing Zhai
Department of Orthopedics, Linyi People's Hospital Affiliated to Shandong University, Linyi, 276000, Shandong, People's Republic of China
1 shared publicationZhen-Xing Wang
Department of Orthopedics, Linyi People's Hospital Affiliated to Shandong University, Linyi, 276000, Shandong, People's Republic of China
1 shared publication
Latest Publications
- 6 January 2015
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 72 (1) , 283-288
Transglutaminase-2 is Involved in Cell Apoptosis of Osteosarcoma Cell Line U2OS Under Hypoxia Condition
Osteosarcoma is the most common type of solid bone cancer, which is the second leading cause of cancer-related death. Hypoxia is an ordinary phenomenon in solid tumor tissues and can induce cell apoptosis but the specific molecular mechanism remains unclear. In this study, we explored the effect and the molecular mechanism of Transglutaminase 2 (TG2) on cell apoptosis in osteosarcoma U2OS cells under hypoxia. We found the enzymatic activity of TG2 is significantly increased and the expression of TG2 is remarkably up-regulated under hypoxia condition. Cell apoptotic rate is markedly increased upon knockdown of TG2 by siRNA under hypoxia. We further investigated the mechanism of cell apoptosis and found Bax protein is significantly increased after depletion of TG2 under hypoxia. Moreover, our data also show that cytochrome C (Cyt C) is significantly increased in cytoplasm and markedly decreased in mitochondria of U2OS cells after depletion of TG2 under hypoxia. Our results suggest that TG2 can inhibit tumor cell apoptosis through down-regulation of Bax and prevention of release Cyt C from mitochondria into cytoplasm.
- 6 January 2015
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 72 (1) , 283-288
Transglutaminase-2 is Involved in Cell Apoptosis of Osteosarcoma Cell Line U2OS Under Hypoxia Condition
Osteosarcoma is the most common type of solid bone cancer, which is the second leading cause of cancer-related death. Hypoxia is an ordinary phenomenon in solid tumor tissues and can induce cell apoptosis but the specific molecular mechanism remains unclear. In this study, we explored the effect and the molecular mechanism of Transglutaminase 2 (TG2) on cell apoptosis in osteosarcoma U2OS cells under hypoxia. We found the enzymatic activity of TG2 is significantly increased and the expression of TG2 is remarkably up-regulated under hypoxia condition. Cell apoptotic rate is markedly increased upon knockdown of TG2 by siRNA under hypoxia. We further investigated the mechanism of cell apoptosis and found Bax protein is significantly increased after depletion of TG2 under hypoxia. Moreover, our data also show that cytochrome C (Cyt C) is significantly increased in cytoplasm and markedly decreased in mitochondria of U2OS cells after depletion of TG2 under hypoxia. Our results suggest that TG2 can inhibit tumor cell apoptosis through down-regulation of Bax and prevention of release Cyt C from mitochondria into cytoplasm.